Literature DB >> 29266266

Characterisation of peptide interactions that regulate PKCε activation.

Indu R Chandrashekaran1, Raymond S Norton1, Carsten Schmitz-Peiffer2,3.   

Abstract

Targeting the interaction between PKC isoforms and their anchoring proteins can specifically regulate kinase activity. εV1-2 and pseudoεRACK peptides, derived from the PKCε C2 domain, modulate its association with receptor for activated C-kinase 2 (RACK2) and thus its function. Details of these interactions remain obscure, and we therefore investigated binding of these peptides using biophysical techniques. Surface plasmon resonance (SPR) indicated that the inhibitory εV1-2 peptide bound to RACK2, and inhibited PKCε binding as expected. In contrast, SPR and NMR demonstrated that the activating pseudoεRACK peptide and related sequences did not bind to PKCε, indicating that their mechanisms of action do not involve binding to the kinase as previously proposed. Our results clarify which interactions could be targeted in developing new therapeutics that inhibit PKCε-RACK2 interaction.
© 2017 Federation of European Biochemical Societies.

Entities:  

Keywords:  C2 domain; RACK2; peptides; protein kinase C; saturation transfer difference NMR; surface plasmon resonance

Mesh:

Substances:

Year:  2018        PMID: 29266266     DOI: 10.1002/1873-3468.12953

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  Endogenous Neurosteroid (3α,5α)3-Hydroxypregnan-20-one Inhibits Toll-like-4 Receptor Activation and Pro-inflammatory Signaling in Macrophages and Brain.

Authors:  Irina Balan; Matthew C Beattie; Todd K O'Buckley; Laure Aurelian; A Leslie Morrow
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

2.  The GABAA Receptor α2 Subunit Activates a Neuronal TLR4 Signal in the Ventral Tegmental Area that Regulates Alcohol and Nicotine Abuse.

Authors:  Irina Balan; Kaitlin T Warnock; Adam Puche; Marjorie C Gondre-Lewis; Harry June; Laure Aurelian
Journal:  Brain Sci       Date:  2018-04-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.